Program helps those with dementia regain ‘lost’ words
By
John O'Connor
Oct 25, 2016
An innovative online speech therapy program is helping seniors with dementia recall words that seemed lost, including the names of their grandchildren.
Study identifies factors that predict driving cessation in seniors
May 22, 2024
Older age, female sex and progression to symptomatic Alzheimer’s disease were associated with driving cessation.
An easier and cheaper way to diagnose Alzheimer’s disease may be on the way
By
John O'Connor
Mar 04, 2020
A simple blood test might soon be all that’s needed to confirm Alzheimer’s disease and frontotemporal dementia.
Retinal layer thickness linked to cognitive decline in older adults
May 27, 2022
Thinner baseline total macular retinal nerve fiber layer thickness was associated with a larger decline in cognitive function test scores during follow-up.
Widespread pain tied to dementia, Alzheimer’s disease, stroke
Aug 17, 2021
After adjustment for multiple variables, widespread pain appeared to increase subsequent risk.
Vestibular system impairment tied to fall risk in Alzheimer’s patients
Mar 18, 2022
A significant association was seen between semicircular canal function with lower likelihood of falls in adjusted analysis.
New model predicts five-year Alzheimer’s dementia risk
Oct 12, 2022
The model includes demographic information, brain imaging test results and genetic biomarkers.
Solanezumab does not slow cognitive decline in preclinical Alzheimer’s disease
Jul 19, 2023
The mean change in Preclinical Alzheimer Cognitive Composite score not significantly different at 240 weeks with solanezumab or placebo.
Benefit of thick liquids in Alzheimer’s disease and dysphagia unclear
May 06, 2024
Patients receiving thick versus thin liquids were less likely to be intubated and more likely to have respiratory complications.
Timing of CSF biomarker divergence for Alzheimer’s disease, normal cognition varies
Feb 21, 2024
Estimated times of divergence of cerebrospinal fluid biomarkers vary from 18 years for Aβ42 to six years for cognitive decline.